TLR9 and Autoimmunity: NET-bound ALRs may potentiate autoimmunity by activating B cells through either endosomal TLR9-NET DNA interactions, or activation of the B cell receptor, in a manner analogous to that reported for the NET-binding peptide LL37 (Gestermann et al., 2018).